BACKGROUND: Prostacyclin (PGI 2 ) plays an important role in mouse embryo development and implantation. However, it is unclear whether its action is mediated via the I prostaglandin receptor (IP). METHODS: We compared the preimplantation development of IP deleted (IP2/2) embryos and wild-type (WT) embryos. We also evaluated the effect of iloprost, a stable PGI 2 analog, and L-165041, a peroxisome proliferator activated receptor d (PPARd) ligand, on IP2/2 versus WT embryos. Finally, we compared the development of heterozygous IP deficient embryos carrying a normal maternal IP allele versus paternal IP allele. RESULTS: Development of IP2/2 embryos lagged behind WT embryos and was not enhanced by either the PGI 2 analog or the PPARd ligand. WT embryos had slightly higher, although statistically not significant, implantation rates than IP2/2 embryos. Heterozygous IP deficient embryos carrying a normal maternal IP allele showed better development and responded to the PGI 2 analog, unlike those carrying the normal paternal IP allele. CONCLUSIONS: IP receptors play an important role in preimplantation embryo development and mediate the embryo's response to exogenous PGI 2 . Early embryo development depends on the oocyte IP receptor.
Introduction
Development of preimplantation embryos in vivo is promoted by a coordinated program involving soluble factors from embryos, oviducts and uterus (Yeung et al., 1992; Hardy and Spanos, 2002) . The overlapping functions of these factors provide a seamless network which optimizes embryo development to ensure the highest implantation potential. Compared with the development of in vivo embryos, the development of cultured embryos is retarded because they are removed from the protective environment of the oviduct (Cohen, 1991; Hardy, 1997) . Prostacyclin (PGI 2 ) is one of the protective factors (Lim et al., 1999; Huang et al., 2003 Huang et al., , 2004a . Our recent work shows supplementing culture media with iloprost, a stable analog of PGI 2 , enhances mouse blastocyst hatching in vitro (Huang et al., 2003) . Cultured embryos preconditioned by iloprost have an enhanced potential for successful implantation and live births when transferred to gestational carriers (Huang et al., 2004b) . On the other hand, blocking endogenous PGI 2 production by selective cyclooxygenase-2 inhibitors retards embryo hatching (Huang et al., 2004c) . Thus, PGI 2 is a crucial endogenous factor for optimal embryo development, and its stable analog effectively augments the hatching and the implantation of cultured embryos.
PGI 2 was originally identified as a product of vascular cells (Moncada et al., 1976) . It inhibits blood platelet aggregation and vascular smooth muscle contraction and is considered to play a crucial role in maintaining vascular homeostasis. The vascular actions of PGI 2 are mediated by a G protein-coupled PGI 2 receptor (IP), which signals classically via cyclic AMP and protein kinase A (Namba et al., 1994) . Other biological actions of PGI 2 , such as embryo implantation (Lim et al., 1999) and cytoprotection (Tan et al., 2001; Hao et al., 2002; Liou et al., 2006) , are proposed to be mediated via a nuclear receptor, peroxisome proliferator activated receptor d (PPARd). Several stable PGI 2 analogs have been shown to bind PPARd (Forman et al., 1997) . Recent work has provided evidence for the involvement of PPARd in the anti-apoptotic action of PGI 2 (Tan et al., 2001; Liou et al., 2006) . It has been reported that PGI 2 up-regulates 14-3-3 e (Liou et al., 2006) and PDK-1 (Di-Poi et al., 2002) via the PPARd pathway. Our recent work indicates that PGI 2 enhances preimplantation embryo development in a PPARd-dependent manner (Huang et al., 2007) . Furthermore, our data based on PPARd deleted mice have shown that PPARd is essential for blastocyst formation and embryo hatching (Huang et al., 2007) . In vitro embryo hatching was completely blocked by PPARd deletion. We have previously shown that the IP is expressed in preimplantation embryos (Huang et al., 2003) . However, its role in preimplantation embryo development has not been delineated.
In this study, we investigated the role of IP in blastocyst formation, embryo hatching and implantation using IP deleted (IP2/2) and wild-type (WT) embryos. We also investigated the responses of IP2/2 embryos to iloprost, a PGI 2 analog.
Material and Methods

Generation of heterozygous IP deficient embryos
The research protocol was approved by the Animal Welfare Committee of the University of Texas Health Science Center, Houston. Unless specified otherwise, all chemicals were purchased from Sigma (St. Louis, MO, USA). The IP2/2 mice have been fully backcrossed onto a C57BL6/J background (Cheng et al., 2002) . The heterozygous IP deficient embryos were generated by mating IP2/2 mice with WT mice of mixed C3H/HeJ and C57BL/6J backgrounds. Heterozygous IP deficient embryos carrying a deficient maternal allele and a normal paternal allele (designated as IP2/þ) were obtained by mating IP2/2 females with males of mixed C3H/HeJ and C57BL/6J backgrounds; those carrying a deficient paternal allele and a normal maternal allele (designated as IPþ/2) were obtained by mating females of mixed C3H/HeJ and C57BL/6J backgrounds with IP2/2 males. Mice were kept in a temperature-and humiditycontrolled environment (07:00 light on, 19:00 light off) with free access to food and water.
Embryo harvest and culture Unless specified otherwise, mouse embryos were harvested and cultured as described previously (Huang et al., 2003) . Briefly, ovulation induction was induced in three-week-old females with intra-peritoneal injection of PMSG (5 IU) followed by hCG (5 IU) 42-46 h later. After hCG injection, each female was caged with one fertile male. Two-cell embryos were harvested 44-48 h later and cultured (17 -20 per group) at 378C under 5% CO 2 in four-well plates (Nalge Nunc International, Naperville, IL, USA) containing 600 ml media. All, except heterozygous IP deficient embryos, were cultured in HTF media (Sage Biopharma, Bedminster, NJ, USA) during the first 48 h, and aMEM (Irvine Scientific, Santa Ana, CA, USA) with Earle's salts and 2 mM glutamine during the second 48 h. Heterozygous IP deficient embryos were cultured in Global media (IVF Online, Guelph, Canada), an improved KSOM media, because our ART laboratory changed the culture system when the experiments were conducted. Preliminary experiments were performed to ensure that embryo development was comparable between the two medium systems. Both medium systems were supplemented with 0.5 mg/ml human albumin substitute (IVF Online). After 96 h of culture, embryos were examined for the presence of zona pellucida. Those completely free of the zona pellucida were considered completely hatched. The rate of complete hatching was calculated by dividing the number of completely hatched embryos by the number of total embryos. Complete embryo hatching was chosen as an end point because it is the final developmental stage prior to implantation and correlates with the potentials of implantation and live birth of embryos (Huang et al., 2003 (Huang et al., ,2004b . During the 96-h period, the developmental stages of embryos were recorded every 24 h. Detailed embryo morphology, such as fragmentation or blastomere appearance, was not recorded. Where indicated, experimental embryos received iloprost (1 mM, Cayman Chemical Co. Ann Arbor, MI, USA), L-165041 (1 mM) or GW 501516 (1 mM) and control embryos received vehicle of same concentration (DMSO, 1:10 000) beginning at 24 h of culture. Based on our previous studies (Huang et al., 2003 (Huang et al., ,2007 , 1 mM of iloprost and L-165041 enhances maximum embryo hatching.
Embryo transfer and determination of implantation rates WT and IP2/2 embryos were harvested at the two-cell stage and cultured for 48 h. All embryos were transferred to 2.5 Day pseudopregnant gestational carriers (7-12 week old ICR females). The embryo transfer was performed as described previously (Huang et al., 2004b) and is summarized as follows. After adequate anesthesia was attained, each uterine horn was accessed via a 1-1.5 cm flank incision under a dissecting microscope (Olympus SZ-PT, Shinjuku-ku, Tokyo, Japan). An opening was created with a 30-gauge needle on the anti-mesenteric side of the distal uterine horn, while the proximal oviduct was held by a pair of forceps. The opening allowed the entry of transfer pipette which had an inner diameter of $140 mm. Up to seven embryos in 1.5 ml transfer medium (MEM with 25 mM HEPES and 1% BSA) were transferred to each horn. After each transfer, the content of the transfer pipette was examined under a stereomicroscope to identify retained embryos. Each gestational carrier received only one type of embryos in order to prevent mixing of embryos (Dr Andreas Zimmer, University of Bonn, Germany, MGI-List, the Jackson Laboratory). Embryo transfer was performed by one individual (J-.C.H.) following the same protocol to ensure consistency. Seventy-two hour after embryo transfer, the implantation rates were determined based on a previously described method with modifications (Paria et al., 1993) . Briefly, 3 min before euthanasia, 0.1 ml of Chicago blue (1%) was injected via the tail vein. After the carrier was euthanized, the blue bands over the uteri were counted and confirmed with the number of gestation sacs inside the uterine horns. The implantation rate was expressed as the number of gestational sacs divided by the number of embryos transferred.
Statistical analysis
GraphPad InStat w (Version 3.05, GraphPad Software Inc., San Diego, USA) software was used for statistical analysis. Two-tailed Fisher's exact test or Chi square test was used to compare the rates. A P , 0.05 was considered statistically significant.
Results
IP2/2 embryos showed retarded development and were unresponsive to PGI 2 We used complete embryo hatching as a surrogate of embryo development in vitro to compare the development of WT and IP2/2 embryos because it correlates with enhanced implantation and live birth (Huang et al., 2004b) . Our results show the development of IP2/2 embryos was retarded: the number of hatched IP2/2 embryos was 56% that of WT embryos (P ¼ 0.02, Fig. 1) . We have previously shown that iloprost enhances embryo hatching (Huang et al., 2003) . In this study, we evaluated the effect of iloprost on IP2/2 and WT embryos. Similar to previous report, iloprost (1 mM) increased WT embryo hatching from 31 to 49% (P ¼ 0.013, Fig. 1 ). In contrast, iloprost did not enhance the hatching of IP2/2 embryos (Fig. 1) . Surprisingly, L-165041, a PPARd ligand, which enhanced WT embryo hatching (Fig. 1) as reported previously (Huang et al., 2007) , also failed to enhance IP2/2 embryo hatching (Fig. 1) . We confirmed these unexpected findings with another synthetic PPARd ligand, GW501516. GW501516 also failed to enhance IP2/2 embryo hatching: eight and ten out of 81 embryos receiving DMSO and GW501516, respectively, hatched completely, P ¼ 0.8).
We next determined if the progression of IP2/2 embryos to blastocysts, as compared with the progression of WT embryos, was retarded. After two-cell staged embryos had been cultured for 48 h they were categorized as '! blastocysts' and ',blastocysts' to include those embryos that had progressed to blastocyst stage (and beyond) and those that had not, respectively. Our results show that the early development of IP2/2 embryos was retarded. Compared with WT embryos, approximately half as many IP2/2 embryos reached the blastocyst stage (and beyond) after 48 h (P , 0.001, Table 1 ). Consistent with our earlier observation (Fig. 1) , the number of hatched IP2/2 embryos was $60% that of WT embryos (P ¼ 0.019). It is worth mentioning that extending the duration of culture to 120 h did not result in more hatched IP2/2 embryos. The majority of blastocysts that did not hatch completely at 96 h became collapsed during the additional 24-h period.
IP2/2 embryos had normal implantation potential
Although the development of IP2/2 embryos was significantly slower than that of WT embryos (Table 1) , IP2/2 mice have not been reported to have smaller litters than WT mice (Murata et al., 1997; Cheng et al., 2002) . Therefore, we used a previously described embryo transfer model (Huang et al., 2004b) to compare the implantation potential of WT and IP2/2 embryos. At the time of embryo transfer, IP2/2 embryos remained largely at the morula stage (67 versus 40% of WT embryos, Table 2 ), more than half of WT embryos had progressed to the blastocyst stage (54 versus 16% of IP2/2 embryos) and three times more IP2/2 embryos than WT embryos (18 versus 6%) had not reached the morula stage. Despite these striking differences in embryo development, the implantation rates of WT and IP2/2 embryos were not significantly different (Fig. 2) . Exposure to iloprost between 24 -48 h neither augmented embryo development (Table 2 ) nor increased implantation rates (Fig. 2) .
IP2/1 embryos (IP2/2 C 3 WT F), but not IP1/2 embryos (WT C 3 IP2/2 F), showed retarded development We generated heterozygous IP deficient embryos from male or female IP2/2 mice and compared their development in vitro to test the hypothesis that IP deficiency during oogenesis affects early embryo development. Our results show IPþ/2 embryos (Table 3) , similar to WT embryos (Table 1) , exhibited normal development during the first 48 h. In contrast, IP2/þ embryos (Table 3) , similar to IP2/2 embryos (Table 1) , exhibited retarded development. However, at 96 h, the percentage of completely hatched IPþ/2 embryos decreased to the same level as that of IP2/2 embryos, whereas the percentage of completely hatched IP2/þ embryos was higher than that of IPþ/2 embryos (Table 3) .
PGI 2 enhanced the development of IP2/1 (IP2/2 C 3 WT F) but not IP1/2 (WT C 3 IP2/2 F) embryos The above results show that two-cell IP2/þ embryos have a reduced developmental potential during the first 48 h of culture. A previous report reveals that the 'window' of response to PGI 2 , in terms of enhanced embryo development, is between 24 and 42 h after harvest of two-cell embryos (Huang et al., 2003) . Therefore, we exposed IPþ/2 embryos and IP2/þ embryos to iloprost beginning at 24 h and compared embryo hatching at 96 h to determine the extent to which IP deficiency in oocytes affected embryo's response to PGI 2 . Our results show that iloprost enhanced IPþ/2 embryo hatching (Fig. 3) to an extent similar to that of WT embryos (Fig. 1) . On the other hand, iloprost did not increase IP2/þ embryo hatching (Fig. 3) .
Discussion
Our results indicate that IP receptors are involved in blastocyst formation and embryo hatching and that the enhancing effects of iloprost in preimplantation embryos require IP receptors. Deletion of IP receptors results in $50% reduction of two-cell embryos reaching the blastocyst stage at 48 h and $40% reduction of completely hatched blastocysts at 96 h. As PGI 2 is produced by cultured embryos (Huang et al., 2004c) , these findings suggest that basal PGI 2 promotes the development of preimplantation embryos in part through IP-mediated signal transduction. We showed previously that iloprost, an exogenous PGI 2 analog, enhances embryo development in vitro (Huang et al., 2003) . The present study shows iloprost no longer enhances embryo hatching when IP receptors are deleted. These findings provide strong evidence that IP receptors play a crucial role in the in vitro development of preimplantation embryos. Heterozygous IP deficient embryos were derived from either WT or IP deficient (IP2/2) females. Those carrying a normal maternal allele were derived from WT females (mixed C3H/HeJ and C57BL/6J backgrounds) and IP2/2 males; those carrying normal paternal allele were derived from WT males (mixed C3H/HeJ and C57BL/ 6J backgrounds) and IP2/2 females. The embryos were cultured in the Global medium supplemented with PGI 2 analog (iloprost, 1 mM) beginning at 24 h; control embryos received vehicle of the same concentration (DMSO, 1:10 000). Complete embryo hatching at 96 h was used as the end point. Numbers in the parentheses indicate the number of completely hatched embryos versus total embryos. a P ¼ 0.009, Fisher's exact test, RR: 1.8, 95% CI: 1.2-2.8 Table 3 . Heterozygous IP deficient embryos derived from IP2/2 females, but not IP2/2 males, showed retarded early development Our results suggest that a cross-talk between IP receptor and PPARd signaling pathways may occur in the preimplantation embryos. We previously reported that embryo development in vitro is completely retarded when PPARd is genetically deleted and that L-165041, a PPARd selective ligand which enhances embryo hatching in vitro, completely loses this effect on PPARd2/2 embryos (Huang et al., 2007) . As L-165041 does not have any known effect on IP receptors, we were surprised to see that L-165041 (and another PPARd selective ligand, GW501516) also did not enhance IP2/2 embryo development. The reason for this phenomenon is not apparent. However, it may be speculated that PPARd activation is modulated by signaling pathways activated by IP receptors. In fact, the retarded development of IP2/2 embryos (which have intact PPARd) may be attributed to the loss of IP-mediated, post-translational modification of PPARd, which contributes to 40 -50% of in vitro embryo development. Post-translational modification of both PPARa and PPARg has previously been reported (Blanquart et al., 2003) .
Understanding IP signaling pathways in the preimplantation embryos may benefit IVF. Although gross reproductive failure was not one of the reported phenotypes of IP2/2 mice (Murata et al., 1997; Cheng et al., 2002) , the litter sizes of WT and IP2/2 mice have not been compared. Nevertheless, the data presented in one of the reports (Murata et al., 1997) suggest that WT and IP2/2 embryos may have subtle differences in reproduction. The genotypic distribution of pups born to heterozygous IP deficient parents shows a small, but significant (P ¼ 0.029) deviation from the Mendelian distribution: 27% WT (78/281), 54% heterozygous IP deficient (152/281) and 18% IP2/2 (51/281) (Murata et al., 1997) . The above distribution suggests that IP2/2 embryos may have inherent flaws such that fewer than expected pups are born. The magnitude of difference (7%) is similar to what we observed in embryo transfer experiments: $6% fewer IP2/2 embryos implant successfully than WT embryos (Fig. 3) . Therefore, the deviation from the Mendelian distribution may be partly attributed to the decreased development and implantation potentials of IP2/2 embryos. It is worth noting that the large difference in embryo hatching between WT and IP2/2 embryos (36 versus 22%, Table 1 ) was not reflected in implantation (54 versus 48%, Fig. 3 ). This suggests that the loss-of-function due to IP deletion was almost fully compensated by uterine factors. It may be argued that as far as reproduction is concerned, the IP signaling pathway is not biologically relevant because IP deletion does not lead to gross reproductive failure. Nonetheless, information gained from studying IP2/2 embryos in vitro may be used to enhance IVF success, because IVF embryos spent a brief but critical time in vitro.
Our results indicate that an intact IP signaling pathway is required to produce oocytes with normal developmental potential. First, significantly more WT than IP2/2 embryos reached blastocyst stage after 48 h (Table 1) . Second, more two-cell staged IPþ/2 embryos (WT C Â IP2/2 F) than IP2/þ embryos (IP2/2 C Â WT F) reached blastocyst stage after 48 h (Table 3) . Third, a similar proportion of IP2/2 embryos (Table 1 ) and IP2/þ embryos (Table III) reached the blastocyst stage after 48 h. And finally, comparable numbers of WT and IPþ/2 embryos reached the blastocyst stage at 48 h (P ¼ 0.28). These results are consistent with the notion that genetic signals required for initial zygote development derive from the oocytes (Seydoux, 1996) . Although the network of signaling pathways in the oocytes governing embryo development remains to be established, our results indicate that IP is a key components of early embryo development.
The development patterns of IPþ/2 and IP2/þ embryos suggest that the maternal IP allele may be silenced (imprinted) after the embryonic genome activation. Although IPþ/2 embryos showed more advanced development than IP2/þ embryos at 48 h, their rates of complete hatching at 96 h were slightly lower than those of IP2/þ embryos (Table 3) . Furthermore, the complete hatching of IP2/þ and IPþ/2 embryos was not different from that of IP2/2 embryos and was 60-70% that of WT embryos. One possible explanation is that embryo-derived PGI 2 (Huang et al., 2004c) activates the IP to optimize embryo development throughout the preimplantation period and that normal maternal and paternal IP alleles are required for IP expression in oocytes/early embryos and late embryos, respectively. As a result, despite the early delay, IP2/þ embryos were able to 'catch up' with IPþ/2 embryos after the activation of the embryonic genome, because the former had normal paternal IP allele. It should be noted that a PGI 2 analog did not augment IP2/þ embryo development because IP2/þ embryos had developmental delay during the first 48 h (details below). On the other hand, although IPþ/2 embryos have an early developmental advantage, they lost the momentum after the oocyte -embryo transition because the inherited maternal IP mRNA degraded and they had a knock out paternal IP allele. Thus, normal maternal and paternal IP alleles ensure PGI 2 can provide a continuous (or basal) impetus to propel the progression of preimplantation embryos ensuring successful and 'on-time' completion of every developmental stage.
Our results suggest that oocytes produced in an IP deficient environment had diminished early developmental potentials, which, in turn, reduced their responsiveness to PGI 2 analogs. Iloprost did not enhance IP2/þ embryo development (Table 1) , but enhanced IPþ/2 embryo development to an extent comparable to WT embryos (Fig. 3) . It has been reported (Huang et al., 2003) that the enhancing effect of PGI 2 has a narrow window: between 24 and 42 h after the harvest of two-cell embryos (corresponding to the eight-cell to morular stage transition). Although the existence of this narrow window of responsiveness could be explained by the timing of IP and PPARd expression (IP and PPARd become detectable by immunohistochemistry at the morular and two-cell stages, respectively), the true reason is unclear. Based on the results presented here, one possible explanation is that embryo-derived PGI 2 , which exert its effects via oocyte-derived IP receptors in early cultured embryos, may be limited. As a result, an exogenous PGI 2 analog such as iloprost may enhance the development of cultured embryos via the same signaling pathway. Further studies are needed to resolve this complex issue.
In conclusion, IP receptors have an important role in preimplantation embryo development and mediate the embryo's response to exogenous PGI 2 . Normal early embryo development requires intact IP receptors in the oocytes. Information gained from studying IP signaling in the preimplantation embryos may be used to enhance IVF success.
